EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

[Translated article] Should Hydroxyisohexyl 3-Cyclohexene Carboxaldehyde (Lyral®) Still be Part of the Baseline Series?

C P Hernández Fernández, L Borrego, A M Giménez Arnau, T Sanz Sánchez, J M Carrascosa Carrillo, V Zaragoza Ninet, E Serra Baldrich, F J Miquel Miquel, J F Silvestre Salvador, S Córdoba Guijarro, A Sánchez Gilo, P Mercader García und 14 weitere

Actas Dermo-Sifiliográficas · 2025-11 · 116 (10) · T1084-T1092

DOI: 10.1016/j.ad.2025.10.016 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Actas Dermo-Sifiliográficas, 2025-11. Verfasst von C P Hernández Fernández und 25 weiteren Autor:innen. Beteiligte Einrichtung: Servicio de Dermatología, Hospital Universitario de Gran Canaria Doctor Negrín, Universidad de Las Palmas de Gran Canaria, Las Palmas de Gran Canaria…. Hauptthemen laut MEDLINE: Dermatitis, Allergic Contact, Cyclohexenes, Aldehydes, Perfume. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Agencia Española de Medicamentos y Productos Sanitarios.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND AND OBJECTIVES: Hydroxyisohexyl 3-cyclohexene carboxaldehyde (HICC), or Lyral®, is a fragrance marker that is part of the Fragrance Mix II (FM II) and is still patched as an independent allergen within the European and other baseline series despite the European Commission banning its use in cosmetics in 2021. We aimed to study the prevalence of sensitization to the HICC in Spain and its simultaneous positivity with the FM II to determine whether it should be part of the Spanish baseline series. MATERIAL AND METHOD: We analyzed all consecutive patients simultaneously patch-tested with HICC and FM II within the Spanish Contact Dermatitis Registry (REIDAC) from June 1st, 2018 to December 31st, 2023. RESULTS: A total of 96 (0.8%) out of 12,029 patients analyzed yielded positive to HICC and 396 (3.3%) to FM II. In 53% and 64% of the patients, respectively, findings were considered currently relevant. A total of 72 out of 96 (75%) HICC positives would be detected if only FM II was patched. CONCLUSIONS: Prevalence of HICC sensitization in Spain is low and has decreased in recent years. HICC is a prohibited fragrance in cosmetics and FM II detects 3 in 4 sensitized patients. Our results suggest that HICC should remain outside the Spanish baseline series and support its exclusion from the European baseline series.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dermatitis, Allergic ContactCyclohexenesAldehydesPerfumeAllergensHumansSpainMaleFemaleAdultMiddle AgedPatch TestsPrevalenceAgedYoung AdultAdolescent

Stichwörter der Autor:innen

Baseline seriesBatería estándarContact dermatitisDermatitis de contactoEspañaHidroxiisohexil 3-ciclohexeno carboxaldehídoHydroxyisohexyl 3-cyclohexene carboxaldehydeLyral®Patch testsPruebas epicutáneasSpain

Substanzen

hydroxyisohexyl 3-cyclohexene carboxaldehydeCyclohexenesAldehydesPerfumeAllergens

Autor:innen und Institutionen

  • Servicio de Dermatología, Hospital Universitario de Gran Canaria Doctor Negrín, Universidad de Las Palmas de Gran Canaria, Las Palmas de Gran Canaria, Las Palmas, Spain. Electronic address: cpherfer@gobiernodecanarias.o…
  • Servicio de Dermatología, Hospital Universitario Insular de Gran Canaria, Universidad de Las Palmas de Gran Canaria, Las Palmas de Gran Canaria, Las Palmas, Spain.
  • Servicio de Dermatología, Hospital del Mar Research Institute, Barcelona, Spain.
  • Servicio de Dermatología, Hospital Universitario Infanta Sofía, Madrid, Spain.
  • Servicio de Dermatología, Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain.
  • Servicio de Dermatología, Hospital General Universitario de Valencia, Valencia, Spain.

Förderung

  • Agencia Española de Medicamentos y Productos Sanitarios

Zitieren

APA

Hernández Fernández, C. P., Borrego, L., Giménez Arnau, A. M., Sanz Sánchez, T., Carrascosa Carrillo, J. M., Zaragoza Ninet, V., Serra Baldrich, E., Miquel Miquel, F. J., Silvestre Salvador, J. F., Córdoba Guijarro, S., Sánchez Gilo, A., Mercader García, P., Navarro Triviño, F., Tous Romero, F., Rodríguez Serna, M., Melé Ninot, G., Ruiz González, I., Gómez de la Fuente, E., Pastor Nieto, M. A., …, & Gallego Descalzo, M. A. (2025). [Translated article] Should Hydroxyisohexyl 3-Cyclohexene Carboxaldehyde (Lyral®) Still be Part of the Baseline Series?. Actas Dermo-Sifiliográficas, 116(10), T1084-T1092. https://doi.org/10.1016/j.ad.2025.10.016

Vancouver

Hernández Fernández CP, Borrego L, Giménez Arnau AM, Sanz Sánchez T, Carrascosa Carrillo JM, Zaragoza Ninet V, et al. [Translated article] Should Hydroxyisohexyl 3-Cyclohexene Carboxaldehyde (Lyral®) Still be Part of the Baseline Series?. Actas Dermo-Sifiliográficas. 2025;116(10):T1084-T1092. doi:10.1016/j.ad.2025.10.016

BibTeX
@article{HernndezFernndez2025,
  author = {Hernández Fernández, C P and Borrego, L and Giménez Arnau, A M and Sanz Sánchez, T and Carrascosa Carrillo, J M and Zaragoza Ninet, V and Serra Baldrich, E and Miquel Miquel, F J and Silvestre Salvador, J F and Córdoba Guijarro, S and Sánchez Gilo, A and Mercader García, P and Navarro Triviño, F and Tous Romero, F and Rodríguez Serna, M and Melé Ninot, G and Ruiz González, I and Gómez de la Fuente, E and Pastor Nieto, M A and Sánchez-Pedreño Guillén, P and Sánchez Pérez, J and Pereyra Rodríguez, J J and Gatica Ortega, M E and González Pérez, R and García Doval, I and Gallego Descalzo, M A},
  title = {[Translated article] Should Hydroxyisohexyl 3-Cyclohexene Carboxaldehyde (Lyral®) Still be Part of the Baseline Series?},
  journal = {Actas Dermo-Sifiliográficas},
  year = {2025},
  volume = {116},
  number = {10},
  pages = {T1084--T1092},
  doi = {10.1016/j.ad.2025.10.016}
}
Kostenlos starten →